Georgina Energy (GEX) , a helium, hydrogen and natural resources development company in Australia, provides the following update on key workstreams across its Hussar and Mt Winter assets.
GEX said “Georgina continues to be focused on multiple workstreams to fulfil obligations for the Hussar drilling permit approval and completion of the Mt Winter acquisition along with implementing preparation of the re-entry plans for Mt Winter and completion of the ALRA agreement with the CLC and the Traditional Owners. Concurrently, we have completed the evaluation of additional re-entry targets which will shape our post-Hussar and Mt Winter work programme.”
Comment: Normal and decent services has been resumed at GEX, now that the persistent crackpot negative commentary on the company has stopped. This allow GEX to get on to with the job and prove its mettle regarding key Hussar and Mt Winter projects.
Cobra (COBR), the mineral exploration and development company advancing a potentially world-class ionic Rare Earth Elements (“REEs”) discovery enriched with dysprosium and terbium at its Boland Project in South Australia, announced it has executed binding documentation to acquire Exploration Licences 6742, 6774 and 6780 (the “New Tenements”) from the Tri-Star Group.
Comment: Not content with already having an already highly prospective footprint, COBR moved forward to expand it, at a time when ionic REEs are hotter than July.
Upland Resources (UPL): A TR1 revealed that the legendary Bolhassan Di has gone up from 3% to 6% on the shareholder register.
Comment: The TR1 will presumably add some fire to the “no smoke without fire” brigade, aggressively fanning the flames of the share price in recent weeks.
Mast Energy (MAST): A TR1 today revealed that Winterflood are in at 10% on the shareholder register of MAST.
Comment: Presumably not all of this is to make a market in the stock. Presumably our market maker friends were impressed by the RNS earlier this month of a successful completion of a £5m Definitive Investment Agreement with Powertree, as was the market in general.
Poolbeg Pharma (POLB), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, announces that the US Food and Drug Administration (“FDA”) has granted Orphan Drug Designation to POLB 001 as an oral preventative therapy for T-cell engager bispecific antibody-induced Cytokine Release Syndrome.
Comment: Given all that POLB has been through it terms of M&A, share price and the recent fundraise, getting the thumbs up from the FDA now must feel like heaven on earth. Indeed, for any biotech, that is precisely what it is.
Avacta Therapeutics (AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced that the preliminary results for year ended December 31, 2024 will now be published on June 4, 2025 as the Group’s auditors have been unable to finalise the audit work connected to the disposal of Launch Diagnostics, which completed post period end, by the originally planned date of May, 29 2025. The Group was notified of this development on May 23, 2025. There is no impact to Avacta’s financial position and cash runway.
Comment: Even when there is nothing untoward, and even if it is merely the auditors wracking up some overtime, delays are never a good look. And of course, they do not normally arise from companies doubling profits every quarter and just about to get promoted to the FTSE 100, it is normally a company on the back foot already. For the shares of AVCT to just be down a couple of percent is a result.
Gem Resources (GEMR) announces that the AGM of the Company will be held on 23 June 2025 at 11am at the offices of Orrick, Herrington & Sutcliffe (UK) LLP (“Scrutineer”) at 9th Floor 107 Cheapside, London, United Kingdom, EC2V 6DN.
Comment: Given that GEMR has been the strong, silent type of late, one can be sure that there will be a lot of interest in this AGM. Be there or be square.
Elementis (ELM), a global specialty chemicals company, today announced that it has simultaneously signed and completed the sale of its Talc business to IMI Fabi S.p.A (“IMI Fabi”), a global talc manufacturer, for an enterprise value of $121m, with net cash proceeds after transaction costs in the region of $55m.
Comment: Given the way that ELM is an £850m market cap company, the odd $55m here or there is not life changing. However, after tariff inspired new lows for the shares last month, we should see a further rebound in the stock.
Cykel AI (CYK) announced its intention to raise gross proceeds of £750,000 by way of a placing of new ordinary shares with institutional and accredited investors. Net proceeds will be used to fund ongoing operations and initiate the Company’s newly approved Bitcoin (“BTC”) Treasury Reserve Strategy, aligning Cykel AI with the growing cohort of public companies integrating digital assets into corporate treasury management.
Comment: Another company getting on the Bitcoin Treasury strategy, and presumably with £750k to deploy, assuming that BTC will get to $1m sooner rather than later.
Defence Holdings (ALRT) today published its Five-Year Strategic Plan, setting out how the Group will scale four core capability areas – Drone Warfare & Aggregation, AI Agents for Defence Operations, Information & Influence Warfare, and Critical Infrastructure Defence to address Europe’s fast-evolving security priorities. The Five-Year Strategic Plan will be published at 9 am on Thursday 29 May on the Company’s website (www.defencetechnologies.com/investors) and also on X, and for regular updates follow https://www.x.com/wearedefence. The Board will host an open investor call on 2 June 2025 at 10:00 BST (09:00 UTC).
Comment: No new board appointment today, but ALRT is keeping the newsflow pumping. This five year plan sounds like something that the Soviet Union might deliver, although ironically within five years the UK could be part of the Russian Federation.
Catenai (CTAI), the AIM quoted provider of digital media and technology, notes that Alludium Ltd has been accepted into NVIDIA Inception, a partnership program designed to nurture cutting-edge start-ups revolutionising industries through AI and data science. This milestone marks a significant step forward in Alludium’s mission.
Comment: A decent update for CTAI’s investee company, something which underlines and validates the Alludium premise. This should allow the recent CTAI rally to stretch its legs still further.
Disclaimer & Declaration of Interest:
The information, investment views, and recommendations in this Zaks Traders Cafe interview are provided for general information purposes only. Nothing in this interview should be construed as a promotion or solicitation to buy or sell any financial product relating to any companies under discussion or referred to or to engage in or refrain from doing so or engage in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.
